Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 10, 2018PLoS ONEOpen Access

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection

View Full Paper
Ask AI
Bookmark
Share

Authors

KSKasia A. SablikErasmus MCMGMarian C. Clahsen‐van GroningenErasmus MCDHDennis A. HesselinkErasmus MC

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sablik et al. (2018) studied this question.

synapsesocial.com/papers/6a17ad66aeefdf6d9c12d76bhttps://doi.org/10.1371/journal.pone.0196552
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children2010 · 175 citations
  2. 2Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation2015 · 73 citations
  3. 3A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation2016 · 153 citations
  4. 4Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants2016 · 76 citations
  5. 5Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection2012 · 398 citations